Balyasny Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,594
Closed -$386K 2931
2025
Q2
$386K Buy
+10,594
New +$384K ﹤0.01% 2393

Other funds holding BME

Balyasny Asset Management's BME Position: Q3 2025 in Review

Balyasny Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q3 2025, closing a stake of 10,594 shares — an estimated $386K sold.

Balyasny Asset Management first reported a position in BME in Q2 2025 and held it in 1 quarter. The position peaked at $386K in Q2 2025. 76 funds tracked by Wall St. Rank hold BME as of Q3 2025.

  • Balyasny Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 10,594 BlackRock Health Sciences Trust shares in Q3 2025, an estimated $386K.
  • Balyasny Asset Management first reported a position in BlackRock Health Sciences Trust in Q2 2025 and held it in 1 quarter.
  • Balyasny Asset Management's BlackRock Health Sciences Trust position peaked at $386K in Q2 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.